Yuval Cohen, Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), sold 126,716 shares at $46.02 ($5.9M) on 2024-06-17, disclosed to the SEC on 2024-06-18.
Scheduled sale ($5.9M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.17 | 12,487 | $626K | 10.6% |
| 2 | $50.17 | 12,487 | $626K | 10.6% |
| 3 | $50.17 | 16,830 | $844K | 14.3% |
| 4 | $50.17 | 16,830 | $844K | 14.3% |
| 5 | $46.02 | 1,770 | $81K | 1.4% |
| 6 | $46.02 | 1,770 |
| $81K |
| 1.4% |
| 7 | $46.02 | 9,333 | $430K | 7.3% |
| 8 | $46.02 | 9,333 | $430K | 7.3% |
| 9 | $42.24 | 1,770 | $75K | 1.3% |
| 10 | $42.24 | 1,770 | $75K | 1.3% |
| 11 | $42.24 | 2,322 | $98K | 1.7% |
| 12 | $42.24 | 2,322 | $98K | 1.7% |
| 13 | $42.24 | 7,179 | $303K | 5.1% |
| 14 | $42.24 | 7,179 | $303K | 5.1% |
| 15 | $42.24 | 11,667 | $493K | 8.4% |
| 16 | $42.24 | 11,667 | $493K | 8.4% |
| Total | $46.57 avg | 126,716 | $5.9M | 100% |
| Filing → |
| CRBP | SELL | 2025-10-27 | $942K | — | Filing → |
| CRBP | SELL | 2025-02-18 | $125K | — | Filing → |
| CRBP | BUY | 2022-08-11 | $988 | — | Filing → |